Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 8:59 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 145–168 of 369 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Bone Mass Clear all

Conditions: Prostate Cancer
Interventions: Zometa; Drug
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older · Male only
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2013
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Osteoporosis
Interventions: Standard Clinical Practice Regimen, Experimental Cyclic Regimen; Drug
Lead sponsor: Health Research, Inc.; Other
Eligibility: 45 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: West Haverstraw, New York

Conditions: Spinal Cord Injuries, Osteoporosis, Metabolic Syndrome
Interventions: Rosuvastatin Calcium, Placebo Oral Tablet, Coenzyme Q10, Calcium Carbonate, Vitamin D; Drug · Dietary Supplement
Lead sponsor: Dr. B. Catharine. Craven; Other
Eligibility: 18 Years to 60 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Osteoporosis
Interventions: Soy protein; Dietary Supplement
Lead sponsor: Creighton University; Other
Eligibility: 55 Years to 72 Years · Female only
Enrollment: 203 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2004
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Thalassemia
Interventions: Zinc, Placebo; Dietary Supplement
Lead sponsor: UCSF Benioff Children's Hospital Oakland; Other
Eligibility: 6 Years to 30 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 3
States / cities: Oakland, California • San Francisco, California • Philadelphia, Pennsylvania

Conditions: Osteopetrosis
Interventions: rhPTH; Drug
Lead sponsor: University of Chicago; Other
Eligibility: 20 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2011
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: HIV Infections
Interventions: Alendronate, Calcium carbonate, Vitamin D; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 25 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 2006
U.S. locations: 28
States / cities: Birmingham, Alabama • Los Angeles, California • San Diego, California + 17 more

Conditions: Osteoporosis, Vascular Calcification, Inflammation
Interventions: Vitamin K; Drug
Lead sponsor: National Institute on Aging (NIA); NIH
Eligibility: 60 Years to 80 Years
Enrollment: 452 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2006
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Bone Density
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 20 Years to 40 Years
Enrollment: 84 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2018
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: MACS Syndrome
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 380 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Survivors of Bone Marrow Transplant, Autologous and Allogeneic
Interventions: Not listed
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 8 Years to 30 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Prostatic Neoplasms, Bone Mineral Density Quantitative Trait Locus 3
Interventions: vitamin D, Placebo; Dietary Supplement
Lead sponsor: University of Rochester; Other
Eligibility: 60 Years to 99 Years · Male only
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Breast Cancer
Interventions: Zoledronic acid, Physical activity intervention; Drug · Behavioral
Lead sponsor: HealthPartners Institute; Other
Eligibility: 40 Years to 55 Years · Female only
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2007
U.S. locations: 1
States / cities: Saint Louis Park, Minnesota

Conditions: Ehlers-Danlos Syndrome, Stickler Syndrome, Marfan Syndrome
Interventions: Not listed
Lead sponsor: National Institute on Aging (NIA); NIH
Eligibility: 2 Years and older
Enrollment: 929 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2015
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Osteoporosis, Bone Loss, Spinal Cord Injury
Interventions: teriparatide, weight-bearing; Drug · Other
Lead sponsor: Thomas J. Schnitzer; Other
Eligibility: 18 Years to 75 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: End-Stage Renal Disease, Hemodialysis
Interventions: Low dialysate calcium, high dialysate calcium; Drug
Lead sponsor: Ege University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 457 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Osteoporosis
Interventions: Placebo, DP001; Drug
Lead sponsor: Deltanoid Pharmaceuticals; Industry
Eligibility: 55 Years to 80 Years · Female only
Enrollment: 157 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 9
States / cities: Upland, California • Indianapolis, Indiana • Bethesda, Maryland + 6 more

Conditions: Anterior Cruciate Ligament Reconstruction (ACLR)
Interventions: Bone-patellar Tendon-bone (BTB), Bone-patellar Tendon-bone (BTB) and Lateral Extra-Articular Tenodesis (LET); Procedure
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 16 Years to 60 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Product Persistence in GI Tract, Kinetics, Rheumatoid Arthritis (RA), Bone Density
Interventions: SBD111 Probiotic Medical Food, SBD121 Probiotic Medical Food; Other
Lead sponsor: Solarea Bio, Inc; Industry
Eligibility: 18 Years to 64 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Waltham, Massachusetts

Conditions: Healthy
Interventions: DHEA; Drug
Lead sponsor: National Institute on Aging (NIA); NIH
Eligibility: 60 Years and older
Enrollment: 144 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2000 – 2005
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Obesity
Interventions: Tirzepatide; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 65 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Heart Transplantation, Liver Transplantation, Bone Resorption
Interventions: Zoledronic acid, Alendronate, Placebo Zoledronic Acid, Placebo Alendronate; Drug · Other
Lead sponsor: Columbia University; Other
Eligibility: 20 Years to 70 Years
Enrollment: 111 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Osteopenia, Osteoporosis
Interventions: Pamidronate, Calcium and vitamin D; Drug
Lead sponsor: Masonic Cancer Center, University of Minnesota; Other
Eligibility: 1 Year to 20 Years
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2022
U.S. locations: 2
States / cities: Minneapolis, Minnesota • Seattle, Washington

Conditions: Epilepsy, Bone Loss, Osteoporosis, Fractures
Interventions: Risedronate, Placebo + Calcium and Vitamin D; Drug
Lead sponsor: Boston VA Research Institute, Inc.; Other
Eligibility: 18 Years to 85 Years · Male only
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2013
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

Zometa on Bone Mineral Density in Prostate Cancer Patients Undergoing Androgen Ablation Therapy

The Treatment of Osteoporosis Using a Combination of Teriparatide (Forteo) and Denosumab

Statin Monotherapy for Treatment of Endocrine Metabolic Disease Risk

Effect of Soy Isoflavones on Bone Mineral Density and Physical Performance Indices

Zinc & Bone Health in Thalassemia: The Think Zinc Study

rhPTH Therapy for Low Turnover Bone Fragility

The Effect of Alendronate, Calcium, and Vitamin D on Bone Mineral Density in HIV Infected Patients

Effect of Vitamin K on Age-Related Bone Loss and Vascular Calcification

Comparison of Xtreme CT and DXA Bone Densitometry

MACS and Healthy Volunteers Bone Study

Musculoskeletal Outcomes After Bone Marrow Transplant

High-dose Vitamin D Supplementation for ADT-induced Side Effects

Effects of Zometa and Physical Activity on Bone Density in Women Receiving Chemotherapy for Breast Cancer

Studies of Heritable Disorders of Connective Tissue

Effect of Parathyroid Hormone (PTH) and Weight-Bearing on Bone in Spinal Cord Injury (SCI)

Effects of Lowering Dialysate Calcium Level on Progression of Coronary Artery Calcification and Bone Histomorphometry

Phase 2 Safety and Efficacy Study of a Vitamin D Compound (DP001) in Postmenopausal Women With Low Bone Mineral Density

The Effect of Lateral Extra-Articular Tenodesis on Lower-Extremity Lean Mass Recovery Following Anterior Cruciate Ligament Reconstruction

Food Trial to Evaluate the Kinetics of the Medical Foods SBD111 and SBD121 Persistence in Healthy Adults

Biological Effects of Dehydroepiandrosterone (DHEA) in the Elderly

GLP-1s to Enhance Lasting Optimal Weight

Zoledronic Acid Versus Alendronate for Prevention of Bone Loss After Organ Transplantation

Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation

Antiepileptic Drugs and Osteoporotic Prevention Trial